Indaptus Therapeutics is trading 16.71% up now at $2.16, with no confirmed company-specific catalyst identified for the September 9 move.
- It rose 51.64% to $1.85 on September 8.
- Recent coverage highlights an earlier 59-million-share resale filing and a September 4 board-member resignation.
- Available market coverage reports no recent news explaining the current rally.